Drug combination of ciprofloxacin and polymyxin B for the treatment of multidrug-resistant Acinetobacter baumannii infections: A drug pair limiting the development of resistance
Polymyxins are considered as last–resort antibiotics to treat infections caused by Acinetobacter baumannii. However, there are increasing reports of resistance in A. baumannii to polymyxins. In this study, inhalable combinational dry powders consisting of ciprofloxacin (CIP) and polymyxin B (PMB) we...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Language: | Inglés |
| Published: |
MDPI
2023
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10568/129079 |
Similar Items: Drug combination of ciprofloxacin and polymyxin B for the treatment of multidrug-resistant Acinetobacter baumannii infections: A drug pair limiting the development of resistance
- Acinetobacter baumannii and Its relationship to carbapenem resistance : a meta-analysis
- Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria
- Low occurrence and clonal relatedness of multi-drug resistant Escherichia coli carrying transmissible colistin resistance mcr-1 genes in Ugandan poultry
- A review of animal health and drug use practices in India, and their possible link to antimicrobial resistance
- Multidrug resistance of Escherichia coli in cats and the level of understanding of cat owners on antimicrobial resistance
- Antimicrobial resistance